The DOI matches its Crossref record; 156 of the 160 references it cites were found in a registry or an index; none of the 220 sources its claims cite is checked for support yet.
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Open accessAbstract
Tic disorders, including Tourette's disorder, present with a wide range of symptom severity and associated comorbidity. This Practice Parameter reviews the evidence from research and clinical experience in the evaluation and treatment of pediatric tic disorders. Recommendations are provided for a comprehensive evaluation to include common comorbid disorders and for a hierarchical approach to multimodal interventions.
Overview
CoChat Summary
TL;DR
This AACAP Practice Parameter synthesizes evidence and clinical consensus on assessing and treating pediatric tic disorders, including Tourette’s disorder, emphasizing comprehensive evaluation for comorbidity and hierarchical multimodal care. It recommends psychoeducation, behavioral therapy (HRT/C-BIT), and medication for moderate-to-severe impairment, while not endorsing deep brain stimulation, repetitive transcranial magnetic stimulation, special diets, or dietary supplements.
Key findings
- Chronic tic disorder (CTD) prevalence is estimated at 0.5% to 3%; approximately 7% of school-age children had tics in the previous year, transient tics approximately 5%, and all tics range from 5.9% to 18% in boys and 2.9% to 11% in girls, with a male preponderance of at least 2:1. Average age of onset is 7 years, peak prevalence/severity is around 9 to 12 years, 65% have remission or marked attenuation by age 18 to 20 years, and 25% have tics into adulthood.
- Comorbidity is common: 20% to 60% of Tourette’s disorder patients meet criteria for OCD and 20% to 38% of youth with OCD report comorbid tics; ADHD co-occurs in as many as 50% of all childhood CTD cases and 60% to 80% of clinically referred TD cases, with ADHD incidence 7 to 8 times greater than in the general population even in mild CTD. Learning disabilities are approximately 23% in youth with chronic tics; 36% of 200 pediatric TD cases had academic difficulties; among 138 youth with CTD, 46% had school-related problems, with comorbid ADHD symptoms at nearly 4-fold increased risk; 4.6% of youth with TD had comorbid ASD.
- Behavioral treatment: in a randomized trial comparing habit reversal training (HRT) to attention control in 25 youth, HRT was associated with a 50% response rate, 30% reduction in tic severity, and approximately 50% reduction in tic-related impairment, with 46% classified as responders versus 25% in the control arm. In the multisite C-BIT trial of 126 youth with TD, 52.5% responded to an 8-session, 10-week HRT-based intervention versus 18.5% in the control condition; tic symptom severity reduction was 51% versus 30%, with a between-groups effect size of 0.64.
- Medication/other: alpha-2 agonists have an effect size of 0.5 for tic amelioration; a meta-analysis found medium-to-large effect (0.68) in trials enrolling subjects with tics and ADHD but only small, nonsignificant benefit (0.15) in trials excluding ADHD. Risperidone was effective in pediatric TD at doses of 1.0 to 3.5 mg/day. Ziprasidone showed a 39% decrease on the YGTSS versus 16% for placebo; atomoxetine resulted in 50% tic reduction versus 33.8% with placebo; metoclopramide resulted in 39% tic reduction versus 13% with placebo; ondansetron had 54% improved versus 21% with placebo. Levetiracetam did not demonstrate significant benefit, and there was no evidence that pramipexole has efficacy in suppressing tics. Deep brain stimulation, repetitive transcranial magnetic stimulation, special diets, and dietary supplements lack empirical support and are not recommended.
Methods
- Literature search used Medline, PubMed, PsycINFO, and Cochrane Library with terms Tourette’s Disorder, Tourette syndrome, or Tic Disorder, English language, human studies, from January 1, 1965 to March 29, 2013, yielding 3,764 Medline citations, 3,172 PsycINFO citations, and 3 Cochrane reviews. The authors selected 149 publications and 25 RCTs that enrolled pediatric subjects with an effective N of at least 20 (Table 2 reports N > 20).
- Recommendations are graded as Clinical Standard [CS], Clinical Guideline [CG], Clinical Option [OP], or Not Endorsed [NE], with empirical evidence rated as randomized controlled trial [rct], controlled trial [ct], uncontrolled trial [ut], or case series/report [cs]. The Parameter was reviewed by experts and a Consensus Group and approved by the AACAP Council on July 29, 2013.
- Main analysis is an evidence synthesis and clinical consensus process producing a hierarchical approach to multimodal assessment and treatment.
Limitations
- Stated in the paper: AACAP Practice Parameters are developed to assist psychiatric decision making and are not intended to define the sole standard of care; they are not inclusive of all proper methods nor exclusive of other methods, and ultimate judgment for a particular patient must be made by the clinician in light of all circumstances, available options, and resources.
- Evident from the text: large, multisite, randomized, placebo-controlled trials for pediatric tic disorders are few; many medication studies enrolled primarily adults; most medication treatment studies target moderate to severe tics and result in symptom reduction but not remission; there are no systematic studies comparing HRT to medication or combined therapies in youth.
- Evident from the text: some areas are understudied, including non-OCD mood/anxiety disorders, explosive/rage symptoms, and complementary/alternative therapies; co-occurrence estimates may be inflated by referral bias because youth with comorbidities may be more likely to seek treatment.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 4 Not valid · 172 Not checked · 21 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“Large, multi-site, randomized, placebocontrolled trials for the treatment of tic disorders are few in number, especially in pediatric populations (Table 2).”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Recommendation 5. Education regarding CTD should be provided regarding expectations for course and prognosis, and treatment planning should consider classroom-based accommodations. [CS]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Active comparator trials (clonidine and pimozide versus risperidone) found risperidone at least as effective.”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Antipsychotic Medications
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“There are no systematic studies to date comparing HRT to medication or combined therapies in youth.”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Recommendation 5. Education regarding CTD should be provided regarding expectations for course and prognosis, and treatment planning should consider classroom-based accommodations. [CS]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There are no controlled pharmacological studies in youth with tic disorders and aggressive/anger outbursts.”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Antipsychotic Medications
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In general, CTD have a male preponderance, with a gender ratio of at least 2:1 or higher.”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > EPIDEMIOLOGY
What the sources say
- Not checked yetcites [11] Bloch, 2006, Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome, Arch Pediatr Adolesc Med source
- Not checked yetcites [20] Scahill, 2009, Prevalence of diagnosed Tourette syndrome in persons Aged 6–17 Years—United States, 2007, Morbid Mortal Wkly Rep source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 197 claims and to verify the 218 references still open.
- It may state two separate claims as one. 49
- Probably not a substantial claim. 37
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yet, for many youngsters, it is not the tics that are most problematic but rather the co-occurring problems many youth experience.51”
From SUICIDAL THOUGHTS AND BEHAVIORS IN CHILDREN AND ADOLESCENTS WITH CHRONIC TIC DISORDERS: Research Article: Suicidal Thoughts in Chronic Tic Disorders (2015) · cites this paper as [51]
In the citing paper
“Although many youth respond to pharmacological and behavioral interventions for CTDs (Murphy et al., 2013), remission is rare and even treatment responders continue to experience tics.”
From Living with tics: Reduced impairment and improved quality of life for youth with chronic tic disorders (2015) · cites this paper as Murphy et al., 2013
In the citing paper
“professional organizations have recommended behavior therapy as the first-line intervention for youth with PTD who have mild-to-moderate tic severity [37–39]”
From Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research (2015) · cites this paper as [37]
In the citing paper
“Although recognized as an important aspect of treatment in evidence-based practice parameters [37], there have only been two studies that have evaluated treatments to address these concerns.”
From Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research (2015) · cites this paper as [37]
In the citing paper
“professional organizations recommend behavior therapy as a first-line intervention for individuals with mild-to-moderate tic severity [37]”
From Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research (2015) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > PARAMETER LIMITATIONS
“TABLE 2 Controlled Trials in Pediatric Tourette's Disorder (TD) with N > 20”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Recommendation 3. The assessment for tic disorders should involve a careful examination for general medical condition or substance etiologies. [CS]
“115 12 8e27 (14.9)Crossover YGTSS Clonidine”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity
LECKMAN, J. F., RIDDLE, M. A., HARDIN, M. T., ORT, S. I., SWARTZ, K. L., STEVENSON, J., & COHEN, D. J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00015 · Cited by 2,146
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., Dow, S., Zamkoff, J., Dubbert, B. K., & Lougee, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.264 · Cited by 1,534
Achenbach, T. M., & Ruffle, T. M. (2000) · Pediatrics in Review · doi:10.1542/pir.21-8-265 · Cited by 1,285
Costello, E. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830120067012 · Cited by 1,083
Freeman, R. D., Fast, D. K., Burd, L., Kerbeshian, J., Robertson, M. M., & Sandor, P. (2000) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200000839 · Cited by 924
Behavior Therapy for Children With Tourette Disorder: A Randomized Controlled Trial
Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., Ginsburg, G. S., Deckersbach, T., Dziura, J., Levi-Pearl, S., et al. (2010) · JAMA · doi:10.1001/jama.2010.607 · Cited by 790
Course of Tic Severity in Tourette Syndrome: The First Two Decades
Leckman, J. F., Zhang, H., Vitale, A., Lahnin, F., Lynch, K., Bondi, C., Kim, Y.-S., & Peterson, B. S. (1998) · Pediatrics · doi:10.1542/peds.102.1.14 · Cited by 685
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635
Research works printed but not linked: 1
- 1998, Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. AACAP, J Am Acad Child Adolesc Psychiatry, 37, 46S
Cited by
Mental Health Surveillance Among Children — United States, 2013–2019
Bitsko, R. H., Claussen, A. H., Lichstein, J., Black, L. I., Jones, S. E., Danielson, M. L., Hoenig, J. M., Davis Jack, S. P., Brody, D. J., Gyawali, S., et al. (2022) · MMWR Supplements · doi:10.15585/mmwr.su7102a1 · Cited by 1,723
Gilles de la Tourette syndrome
Robertson, M. M., Eapen, V., Singer, H. S., Martino, D., Scharf, J. M., Paschou, P., Roessner, V., Woods, D. W., Hariz, M., Mathews, C. A., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.97 · Cited by 347
A meta-analysis of behavior therapy for Tourette Syndrome
McGuire, J. F., Piacentini, J., Brennan, E. A., Lewin, A. B., Murphy, T. K., Small, B. J., & Storch, E. A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.12.009 · Cited by 334
Self-citationPsychobiotics in mental health, neurodegenerative and neurodevelopmental disorders
Cheng, L.-H., Liu, Y.-W., Wu, C.-C., Wang, S., & Tsai, Y.-C. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2019.01.002 · Cited by 291
Borcherding, B., Rendleman, R. L., & Walkup, J. T. (2017) · Swaiman's Pediatric Neurology · doi:10.1016/b978-0-323-37101-8.00060-6 · Cited by 286
Thienemann, M., Murphy, T., Leckman, J., Shaw, R., Williams, K., Kapphahn, C., Frankovich, J., Geller, D., Bernstein, G., Chang, K., et al. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0145 · Cited by 149
Self-citationRicketts, E. J., Goetz, A. R., Capriotti, M. R., Bauer, C. C., Brei, N. G., Himle, M. B., Espil, F. M., Snorrason, Í., Ran, D., & Woods, D. W. (2016) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x15593192 · Cited by 100
Sallee, F. R., Kohegyi, E., Zhao, J. L., McQuade, R. D., Cox, K., Sanchez, R., van Beek, A., Nyilas, M., Carson, W. H., & Kurlan, R. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0026 · Cited by 144
Singer, H. S. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000752 · Cited by 137
Moderators and predictors of response to behavior therapy for tics in Tourette syndrome
Sukhodolsky, D. G., Woods, D. W., Piacentini, J. C., Wilhelm, S., Peterson, A. L., Katsovich, L., Dziura, J. D., Walkup, J. T., & Scahill, L. D. (2017) · Neurology · doi:10.1212/wnl.0000000000003710 · Cited by 133
A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale
Mcguire, J. F., Piacentini, J. C., Storch, E. A., Murphy, T. K., Ricketts, E. J., Woods, D. W., Walkup, J., Peterson, A. L., Wilhelm, S., Lewin, A. B., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005474 · Cited by 115
Self-citationMcGuire, J. F., Arnold, E., Park, J. M., Nadeau, J. M., Lewin, A. B., Murphy, T. K., & Storch, E. A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.045 · Cited by 114
Self-citationTics and Tourette's: update on pathophysiology and tic control
Ganos, C. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000356 · Cited by 101
McGuire, J. F., Ricketts, E. J., Piacentini, J., Murphy, T. K., Storch, E. A., & Lewin, A. B. (2015) · Current developmental disorders reports · doi:10.1007/s40474-015-0063-5 · Cited by 92
Self-citationRizzo, R., Pellico, A., Silvestri, P. R., Chiarotti, F., & Cardona, F. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00100 · Cited by 70
Wolicki, S. B., Bitsko, R. H., Danielson, M. L., Holbrook, J. R., Zablotsky, B., Walkup, J. T., Woods, D. W., & Mink, J. W. (2019) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000667 · Cited by 85
Meta-analysis: Adulthood prevalence of Tourette syndrome
Levine, J. L. S., Szejko, N., & Bloch, M. H. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109675 · Cited by 85
Murphy, T. K., Fernandez, T. V., Coffey, B. J., Rahman, O., Gavaletz, A., Hanks, C. E., Tillberg, C. S., Ibanez-Gomez, L., Sukhodolsky, D. G., Katsovich, L., et al. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0024 · Cited by 80
Self-citationMcGuire, J. F., Piacentini, J., Scahill, L., Woods, D. W., Villarreal, R., Wilhelm, S., Walkup, J. T., & Peterson, A. L. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.05.006 · Cited by 45
Cognitive Behavior Therapy for Obsessive-Compulsive and Related Disorders
Lewin, A. B., Wu, M. S., Mcguire, J. F., & Storch, E. A. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.05.002 · Cited by 75
Self-citationTics in the Pediatric Population: Pragmatic Management
Ganos, C., Martino, D., & Pringsheim, T. M. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12428 · Cited by 74
Behavioral therapy for Tourette syndrome and chronic tic disorders
Fründt, O., Woods, D. W., & Ganos, C. (2017) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000348 · Cited by 74
Tics and Tourette: a clinical, pathophysiological and etiological review
Dale, R. C. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000546 · Cited by 72
Coulombe, M., Elkaim, L. M., Alotaibi, N. M., Gorman, D. A., Weil, A. G., Fallah, A., Kalia, S. K., Lipsman, N., Lozano, A. M., & Ibrahim, G. M. (2018) · Journal of Neurosurgery Pediatrics · doi:10.3171/2018.7.peds18300 · Cited by 71
Storch, E. A., Hanks, C. E., Mink, J. W., McGuire, J. F., Adams, H. R., Augustine, E. F., Vierhile, A., Thatcher, A., Bitsko, R., Lewin, A. B., et al. (2015) · Depression and Anxiety · doi:10.1002/da.22357 · Cited by 70
Self-citationThe Role of Atypical Antipsychotics for Treatment of Tourette’s Syndrome: An Overview
Budman, C. L. (2014) · Drugs · doi:10.1007/s40265-014-0254-0 · Cited by 66
Tinker, S. C., Bitsko, R. H., Danielson, M. L., Newsome, K., & Kaminski, J. W. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114684 · Cited by 60
Bullying Victimization and Perpetration Among US Children with and Without Tourette Syndrome
Charania, S., Danielson, M. L., Claussen, A. H., Lebrun‐Harris, L. A., Kaminski, J. W., & Bitsko, R. H. (2021) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000975 · Cited by 57
The Effect of Fecal Microbiota Transplantation on a Child with Tourette Syndrome
Zhao, H., Shi, Y., Luo, X., Peng, L., Yang, Y., & Zou, L. (2017) · Case Reports in Medicine · doi:10.1155/2017/6165239 · Cited by 57
Ricketts, E. J., Mcguire, J. F., Chang, S. W., Bose, D., Rasch, M., Woods, D. W., Specht, M. W., Walkup, J. T., Scahill, L. D., Wilhelm, S., et al. (2017) · Behavior Therapy · doi:10.1016/j.beth.2017.05.006 · Cited by 56
Effect of behavior therapy for Tourette's disorder on psychiatric symptoms and functioning in adults
Mcguire, J. F., Ricketts, E. J., Scahill, L. D., Wilhelm, S., Woods, D. W., Piacentini, J. C., Walkup, J. T., & Peterson, A. L. (2019) · Psychological Medicine · doi:10.1017/s0033291719002150 · Cited by 54
Sleep, anxiety and psychiatric symptoms in children with Tourette syndrome and tic disorders
Modafferi, S., Stornelli, M., Chiarotti, F., Cardona, F., & Bruni, O. (2016) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.05.003 · Cited by 54
Mechanisms Underlying Behavior Therapy for Tourette’s Disorder
Essoe, J. K.-Y., Ramsey, K. A., Singer, H. S., Grados, M. A., & Mcguire, J. F. (2021) · Current Developmental Disorders Reports · doi:10.1007/s40474-021-00225-1 · Cited by 53
Sukhodolsky, D. G., Walsh, C. J., Koller, W. N., Eilbott, J. A., Rance, M., Fulbright, R. K., Zhao, Z., Bloch, M. H., King, R. A., Leckman, J. F., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.035 · Cited by 53
Long-term Outcomes of Behavior Therapy for Youth With Tourette Disorder
Espil, F. M., Woods, D. W., Specht, M. W., Bennett, S. M., Walkup, J. T., Ricketts, E. J., Mcguire, J. F., Stiede, J. T., Schild, J. S., Chang, S. W., et al. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.08.022 · Cited by 53
Coffey, B. J., Jankovic, J. J., Claassen, D. O., Shahed, J. J., Gertz, B. J., Garofalo, E. A., Stamler, D. A., Wieman, M., Savola, J., Gordon, M. F., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.29397 · Cited by 52
Jankovic, J. J., Coffey, B. J., Claassen, D. O., Shahed, J. J., Gertz, B. J., Garofalo, E. A., Stamler, D. A., Wieman, M., Savola, J., Gordon, M. F., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.28204 · Cited by 50
Intensive Outpatient Comprehensive Behavioral Intervention for Tics: A Clinical Replication Series
Blount, T. H., Raj, J. J., & Peterson, A. L. (2018) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2017.02.001 · Cited by 22
Clinical Correlates and Mediators of Self-Concept in Youth with Chronic Tic Disorders
Hanks, C. E., Mcguire, J. F., Lewin, A. B., Storch, E. A., & Murphy, T. K. (2015) · Child Psychiatry & Human Development · doi:10.1007/s10578-015-0544-0 · Cited by 48
Self-citationSuicidal ideation in youth with tic disorders
Johnco, C. J., Mcguire, J. F., McBride, N. M., Murphy, T. K., Lewin, A. B., & Storch, E. A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.027 · Cited by 47
Self-citationEvidence-based treatment of Tourette’s disorder and chronic tic disorders
Essoe, J. K.-Y., Grados, M. A., Singer, H. S., Myers, N. S., & Mcguire, J. F. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1643236 · Cited by 46
An International Survey of Health Care Services Available to Patients With Tourette Syndrome
Bhikram, T., Elmaghraby, R., Abi-Jaoude, E., & Sandor, P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.621874 · Cited by 33
Optimizing behavior therapy for youth with Tourette’s disorder
McGuire, J. F., Ginder, N., Ramsey, K., Essoe, J. K.-Y., Ricketts, E. J., McCracken, J. T., & Piacentini, J. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0762-4 · Cited by 18
Interventions for tic disorders: An overview of systematic reviews and meta analyses
Yang, C., Hao, Z., Zhu, C., Guo, Q., Mu, D., & Zhang, L. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.12.013 · Cited by 44
Efficacy of Parent-Delivered, Home-Based Therapy for Tics
Singer, H. S., McDermott, S. M., Ferenc, L. M., Specht, M., & Mahone, E. M. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.12.015 · Cited by 43
Defining tic severity and tic impairment in Tourette Disorder
Mcguire, J. F., Piacentini, J. C., Storch, E. A., Ricketts, E. J., Woods, D. W., Peterson, A. L., Walkup, J. T., Wilhelm, S., Ramsey, K. A., Essoe, J. K.-Y., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.040 · Cited by 41
Self-citationUpdate on the Pharmacological Treatment of Tics with Dopamine-Modulating Agents
Mogwitz, S., Buse, J., Wolff, N., & Roessner, V. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00460 · Cited by 40
An exploratory study into an adapted use of the Alert Program for tic disorder in children
Soler, N., Hardwick, C., Perkes, I. E., Dossetor, D. R., Bray, P., & Dale, R. C. (2018) · Australasian Psychiatry · doi:10.1177/1039856218815750 · Cited by 39
Cingulate role in Tourette syndrome
O’Neill, J., Piacentini, J. C., & Peterson, B. S. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64196-0.00011-x · Cited by 39
Ricketts, E. J., Wolicki, S. B., Danielson, M. L., Rozenman, M. S., Mcguire, J. F., Piacentini, J. C., Mink, J. W., Walkup, J. T., Woods, D. W., & Bitsko, R. H. (2021) · Child Psychiatry & Human Development · doi:10.1007/s10578-020-01111-4 · Cited by 38
Li, H., Wang, Y., Zhao, C., Liu, J., Zhang, L., & Li, A. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001885 · Cited by 37
An initial study of family accommodation in children and adolescents with chronic tic disorders
Storch, E. A., Johnco, C. J., Mcguire, J. F., Wu, M. S., McBride, N. M., Lewin, A. B., & Murphy, T. K. (2016) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-016-0879-5 · Cited by 37
Self-citationCavanna, A. E., Seri, S., & Cox, J. H. (2016) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s87121 · Cited by 36
Brain functional connectivity in chronic tic disorders and Gilles de la Tourette syndrome
Naro, A., Billeri, L., Colucci, P. V., Cause, M. L., Domenico, C. D., Ciatto, L., Bramanti, P., Bramanti, A., & Calabrò, R. S. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101884 · Cited by 35
Benítez‐Burraco, A., & Progovac, L. (2021) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0188 · Cited by 35
Neurocognitive correlates of treatment response in children with Tourette's Disorder
Chang, S. W., Mcguire, J. F., Walkup, J. T., Woods, D. W., Scahill, L. D., Wilhelm, S., Peterson, A. L., Dziura, J., & Piacentini, J. C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.066 · Cited by 34
Rapid-Response Behavioral Triage for Tics (RRBTT): A 2-Week Clinical Case Series
Kennedy, T. M., Morris, A. T., Walkup, J. T., Barash, M., Gettings, J. M., Hankinson, J. C., Reynolds, E. K., Perry-Parrish, C. K., Ostrander, R. S., & Specht, M. W. (2016) · Clinical Practice in Pediatric Psychology · doi:10.1037/cpp0000151 · Cited by 33
The neuropsychiatry of Gilles de la Tourette syndrome: The état de l’art
Cavanna, A. E. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.06.006 · Cited by 33
A Review of Cognitive and Behavioral Interventions for Tic Disorder
Kim, K. M., Bae, E. J., Lee, J., Park, T. W., & Lim, M. H. (2021) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.200042 · Cited by 33
Besag, F., Vasey, M. J., Lao, K. S. J., Chowdhury, U., & Stern, J. S. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211032445 · Cited by 33
Ogundele, M. O., & Ayyash, H. F. (2018) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v7.i1.36 · Cited by 33
Fits, Tantrums, and Rages in TS and Related Disorders
Budman, C. L., Rosen, M., & Shad, S. (2015) · Current Developmental Disorders Reports · doi:10.1007/s40474-015-0059-1 · Cited by 31
Yang, C., Hao, Z., Zhang, L., Zhu, C., Zhu, P., & Guo, Q. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-124872 · Cited by 31
Comprehensive behavioural intervention for tics: a neurophysiological intervention
Eapen, V., Črnčec, R., Pick, A. X., Tsao, O., Lai, R., Lee, J., & Sowman, P. F. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2103089 · Cited by 30
Complexities for Assessment and Treatment of Co-Occurring ADHD and Tics
Coffey, B. J. (2015) · Current Developmental Disorders Reports · doi:10.1007/s40474-015-0061-7 · Cited by 30
Neurobehavioral aspects, pathophysiology, and management of Tourette syndrome
Shprecher, D., Schrock, L. E., & Himle, M. B. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000119 · Cited by 30
Expert consensus on pharmacotherapy for tic disorders in Japan
Hamamoto, Y., Fujio, M., Nonaka, M., Matsuda, N., Kono, T., & Kano, Y. (2019) · Brain and Development · doi:10.1016/j.braindev.2019.02.003 · Cited by 30
Cognitive control processes in behavior therapy for youth with Tourette’s disorder
Mcguire, J. F., Sturm, A., Ricketts, E. J., Montalbano, G. E., Chang, S. W., Loo, S. K., Woods, D. W., McCracken, J. T., & Piacentini, J. C. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13470 · Cited by 30
Changing Patterns of Alpha Agonist Medication Use in Children and Adolescents 2009–2011
Fiks, A. G., Mayne, S. L., Song, L., Steffes, J., Liu, W., McCarn, B., Margolis, B., Grimes, A., Gotlieb, E. M., Localio, R., et al. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0122 · Cited by 29
Homework adherence predicts therapeutic improvement from behavior therapy in Tourette's disorder
Essoe, J. K.-Y., Ricketts, E. J., Ramsey, K. A., Piacentini, J. C., Woods, D. W., Peterson, A. L., Scahill, L. D., Wilhelm, S., Walkup, J. T., & Mcguire, J. F. (2021) · Behaviour Research and Therapy · doi:10.1016/j.brat.2021.103844 · Cited by 29
Social Deficits and Autism Spectrum Disorders in Tourette’s Syndrome
Hanks, C. E., Lewin, A. B., Mutch, P. J., Storch, E. A., & Murphy, T. K. (2015) · Current Developmental Disorders Reports · doi:10.1007/s40474-015-0060-8 · Cited by 28
Self-citationLeclerc, J. B., O’Connor, K. P., J.-Nolin, G., Valois, P., & Lavoie, M. E. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00135 · Cited by 28
Quality assessment of clinical practice guidelines on tic disorders with AGREE II instrument
Yang, C., Zhang, Z., Zhang, L., Tian, J., Yu, D., Wang, J., & Yang, J. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.08.060 · Cited by 26
Yu, L., Li, Y., Zhang, J., Yan, C., Wen, F., Yan, J., Wang, F., Liu, J., & Cui, Y. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1826933 · Cited by 22
Abbasi, P., Tanhaie, S., & Kazeminia, M. (2023) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-023-01562-0 · Cited by 26
Chen, S., Barner, J. C., & Cho, E. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.8.1035 · Cited by 26
Shou, S., Li, Y., Fan, G., Zhang, Q., Yan, Y., Lv, T., & Wang, J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.851250 · Cited by 25
Adaptation of Behavioral Treatment for Youth with Tourette’s Syndrome and Complex Comorbidity
Bolen, M., Bolton, C., & Lewin, A. B. (2022) · Current Developmental Disorders Reports · doi:10.1007/s40474-022-00266-0 · Cited by 24
Self-citationThe Challenges of Identifying Tics in Children
Lewin, A. B., Peris, T. S., & Himle, M. B. (2024) · Evidence-Based Practice in Child and Adolescent Mental Health · doi:10.1080/23794925.2024.2345231 · Cited by 24
Self-citationTourette syndrome increases risk of bone fractures: a population-based cohort study
Lu, Y., Wang, M., Wei, I., Lin, C.-C., & Huang, C. (2016) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-016-0916-4 · Cited by 24
Ricketts, E. J., Gilbert, D. L., Zinner, S. H., Mink, J. W., Lipps, T. D., Wiegand, G. A., Vierhile, A., Ely, L. J., Piacentini, J. C., Walkup, J. T., et al. (2015) · Journal of Child Neurology · doi:10.1177/0883073815599257 · Cited by 24
Pringsheim, T. M. (2017) · Child Psychiatry & Human Development · doi:10.1007/s10578-017-0718-z · Cited by 22
Jiao, F., Zhang, X., Zhang, X., & Wang, J. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2015.10.002 · Cited by 22
Mcguire, J. F., Park, J. M., Wu, M. S., Lewin, A. B., Murphy, T. K., & Storch, E. A. (2014) · Children s Health Care · doi:10.1080/02739615.2014.912944 · Cited by 20
Self-citationLewin, A. B., Mink, J. W., Bitsko, R. H., Holbrook, J. R., Parker-Athill, E. C., Hanks, C. E., Storch, E. A., Augustine, E. F., Adams, H., Vierhile, A., et al. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0128 · Cited by 19
Self-citationAssessment and Management of Tic Disorders in Pediatric Primary Care Settings
Yadegar, M., Guo, S., Ricketts, E. J., & Zinner, S. H. (2019) · Current Developmental Disorders Reports · doi:10.1007/s40474-019-00168-8 · Cited by 18
Yan, J., Cui, L., Wang, M., Cui, Y., & Li, Y. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2103097 · Cited by 17
Pharmacoepidemiology of Tourette and Chronic Tic Disorders in Sweden 2005–2013
Carulla‐Roig, M., Isomura, K., Pérez-Vigil, A., Larsson, H., Hellner, C., Mataix‐Cols, D., & de la Cruz, L. F. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0169 · Cited by 17
Chen, S., Su, Y., Wang, L.-Y., Hsu, C. Y., & Shen, Y. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.02.033 · Cited by 17
Ramsey, K. A., Nadai, A. S. D., Espil, F. M., Ricketts, E. J., Stiede, J. T., Schild, J. S., Specht, M. W., Woods, D. W., Bennet, S., Walkup, J. T., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.929413 · Cited by 17
Aripiprazole for the treatment of Tourette syndrome
Cox, J. H., & Cavanna, A. E. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1893693 · Cited by 17
Treatment use among children with Tourette syndrome living in the United States, 2014
Wolicki, S. B., Bitsko, R. H., Holbrook, J. R., Danielson, M. L., Zablotsky, B., Scahill, L. D., Walkup, J. T., Woods, D. W., & Mink, J. W. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113400 · Cited by 15
Taxonomy and utility in the diagnostic classification of mental disorders
Evans, S. C., Roberts, M. C., Guler, J., Keeley, J. W., & Reed, G. M. (2021) · Journal of Clinical Psychology · doi:10.1002/jclp.23125 · Cited by 15
Thom, R. P., & McDougle, C. J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00731 · Cited by 15
Tan, M. E., Aksu, G. G., & Toros, F. (2020) · Çocuk ve Gençlik Ruh Sağlığı Dergisi / Turkish Journal of Child and Adolescent Mental Health · doi:10.4274/tjcamh.galenos.2020.58077 · Cited by 14
Kohler, K., Rosen, N. E., & Piacentini, J. C. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0023 · Cited by 14
Current and emerging pharmacotherapeutic strategies for Tourette syndrome
Cavanna, A. E. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2107902 · Cited by 14
Jaffe, R. J., & Coffey, B. J. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.03.004 · Cited by 13
Viefhaus, P., Feldhausen, M., Görtz-Dorten, A., Volk, H., Döpfner, M., & Woitecki, K. (2020) · Behavior Modification · doi:10.1177/0145445518796203 · Cited by 11
Indicators of Social Competence and Social Participation Among US Children With Tourette Syndrome
Bitsko, R. H., Danielson, M. L., Leeb, R. T., Bergland, B., Fuoco, M. J., Ghandour, R. M., & Lewin, A. B. (2020) · Journal of Child Neurology · doi:10.1177/0883073820924257 · Cited by 13
Self-citation
Metadata
- Authors
- Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 52
- Issue
- 12
- Pages
- 1341-1359
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2960535177
- Semantic Scholar
- bc1943b6e0ff21b59ab7bfa16642ca3643cab9a5
- Cited by
- 276
- References
- 160
- Citations by year
- 2026: 9 · 2025: 32 · 2024: 17 · 2023: 12 · 2022: 22 · 2021: 29 · 2020: 34 · 2019: 23 · 2018: 23 · 2017: 27 · 2016: 18 · 2015: 20 · 2014: 8 · 2013: 1
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- American Academy of Child and Adolescent Psychiatry
- International OCD Foundation
- University of South Florida
- Otsuka America Pharmaceutical
- National Alliance for Research on Schizophrenia and Depression
- Otsuka America
- Shire
- National Institutes of Health (UL1TR000077)
- Centers for Disease Control and Prevention
- National Institute of Mental Health
- National Center for Advancing Translational Sciences
- Janssen Pharmaceuticals
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Clinical Psychology › Stuttering Research and Treatment
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- tic disorders, Tourette syndrome, comorbidities, multimodal therapy, treatment guidelines, clinical evaluation, children and adolescents
- MeSH terms
- Adolescent, Child, Humans, Tic Disorders, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.